David Baram is the founder of EmendoBio, Inc.. EmendoBio, Inc. has raised $318M in total funding. Latest round: Series A.
David Baram is the co-founder and CEO of EmendoBio, Inc., a biotechnology company focused on curing disease through novel therapeutic approaches. He led Emendo from the pre-seed stage through multiple financing rounds and a successful acquisition in 2020.
Full founder directory · Investor directory · Company funding database · Fundraising library